Financial News
Celgene CEO: New therapies for a certain type of cancer boost survival rates 10-fold
December 11, 2017 at 13:48 PM EST
Celgene and Bluebird Bio find results in treating patients with multiple myeloma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
